ABVC BioPharma, Inc. (ABVC)

EBITDA Growth

-167.51%

TTM · Period ending:

ABVC logo

ABVC EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-167.51%
ABVC TTM EBITDA YoY % (-74.33% → -167.51%)
High-resolution chart · PNG

ABVC ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

ABVC BioPharma, Inc. EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-167.5142%
-460.9572%
-124.1527%
17.45%
62.2192%
81.72%
54.863%
40.0779%
30.1885%
17.8148%
46.4861%
46.4397%
31.326%
32.0392%
-38.5103%
-77.241%
-56.4312%
-55.7656%
-5.7836%
-54.5852%
-86.9542%
-163.9881%
-198.624%
-1.4118%
6.4098%
35.3347%
41.3637%
-171.1585%
-5.9784%
-19.9916%
-36.8557%
43.8404%
50.0971%
54.9866%
75.6237%
76.1475%
-59.3812%
-67.7631%
-51,259.2751%
-56,053.0767%
-1,686,408.7591%
-627,522.474%
-49,287.1429%
96.423%
104.4201%
99.9544%
64.8258%
90.7232%
73.0049%
97.2562%
84.9716%
66.9027%
24.0837%
-51.9211%
-40.2954%
59.3064%
66.2668%
53.7285%
8.6967%
43.5601%
31.4426%
5.9132%
3.0032%
-357.9625%
-501.4119%
-394.2669%
-295.5845%
-9,788.2012%
-8,288.4546%
-8,775.1778%
-5,518.9611%
-822.4292%
-3,794.6387%
-885.0449%
-1,679.2929%
106.615%
98.7695%
106.6867%
95.38%
-74.325%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.